Adoption allows ICON to take full advantage of the Medidata “Data Experience,” leveraging AI to unify data sources, standardize outputs, and reduce reconciliation efforts
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, announced that ICON plc, a world-leading clinical research organization powered by healthcare intelligence, will immediately begin utilizing Medidata Clinical Data Studio on its studies, differentiating ICON as the first large CRO to fully infuse this technology into its clinical workflows.
The integration of Clinical Data Studio into ICON’s service offerings helps unlock the full potential of the Medidata Data Experience, merging information from both Medidata and non-Medidata sources, fast-tracking decision making, and enabling AI-based risk assessment strategies for sites and sponsors. Medidata’s unique AI and automation offerings are the backbone of Clinical Data Studio, and enhance the user experience to simplify aggregation, standardization, and management, granting real-time data access for ICON throughout the clinical trial journey. As a result, the organization can enhance cross-functional collaboration, improve operational oversight, and execute a consolidated strategy, ultimately enabling faster and higher quality trials.
Health Technology Insights: Viz.ai, Study Shows AI Improves Communication in Stroke Patients with Cardiac Shunts
“ICON leads in risk-based quality management, integrating Data Management and Central Monitoring teams in our Clinical Data Science group. To meet growing data demands and customer expectations for speed and efficiency, we selected Clinical Data Studio. This platform streamlines data review, central monitoring, and medical review processes using AI and statistical modeling for faster, precise data delivery,” said Evan Hughes, vice president, clinical data science, ICON.
Health Technology Insights: Rimidi 2.0 Platform Unlocks New Possibilities in Healthcare Innovations
“With our AI-powered Clinical Data Studio, ICON is reimagining clinical data science, maximizing efficiency, speed, and quality,” said Tom Doyle, chief technology officer, Medidata. “We’re providing the technology and capabilities that empower ICON and their customers to unlock unprecedented insights, and accelerate the delivery, at scale, of life-changing therapies to patients worldwide.”
Built on a 20-year relationship, Medidata has supported ICON in more than 1,700 studies, with over 400 active studies underway in therapeutic areas including oncology, central nervous system, vaccine therapies, and more. During this timespan, ICON has also leveraged Medidata eCOA and Medidata Designer to manage its clinical operations and assist sponsors, sites, and patients.
Health Technology Insights: Capsa Healthcare Unveils Innovation Center for Healthcare Solutions
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – businesswire
